Pretzel Therapeutics
USAWho owns Pretzel Therapeutics?
Pretzel Therapeutics is an American Biotech company, currently owned by GU Ventures since 2022 and 4 other investors.
Hand-verified · updated 2026-06-21
Open JSON · CC-BY
Key facts
- ·Co-held by Angelini Ventures, GU Ventures, Eir Ventures, HealthCap and Cambridge Innovation Capital since 2021.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
More from CIC Fund II
Other portfolio companies in the same fund.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Pretzel Therapeutics?
Pretzel Therapeutics is currently owned by GU Ventures, Eir Ventures and 3 others, through CIC Fund II, since 2022.
When did GU Ventures and 4 others acquire Pretzel Therapeutics?
GU Ventures and 4 others acquired Pretzel Therapeutics in 2022.
Who has owned Pretzel Therapeutics over time?
Pretzel Therapeutics has been through 5 private-equity ownership periods: Angelini Ventures · via Angelini Ventures · since 2021; GU Ventures · via GU Ventures Evergreen · since 2022; Eir Ventures · via Eir Ventures I · since 2022; HealthCap · via HealthCap VIII · since 2022; Cambridge Innovation Capital · via CIC Fund II · since 2022.